Clinical trial
Modafinil vs Placebo for the Treatment of Methamphetamine Dependence
NCT00469508 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00469508 |
|---|---|
| Title | Modafinil vs Placebo for the Treatment of Methamphetamine Dependence |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Evaluation of Modafinil vs Placebo for the Treatment of Methamphetamine Dependence |
| Acronym | Modafinil |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Methamphetamine Dependence |
| Intervention type | Drug |
| Interventions | Modafinil, Placebo |
| Enrollment | 71 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | May 4, 2007 |
| Last update posted | Mar 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: